Director · NovoCure Ltd (NVCR)

Asaf Danziger — NovoCure Director Compensation (2025)

Fiscal year 2025 director compensation for Asaf Danziger at NovoCure Ltd. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 20, 2026 (DEF 14A). Open the filing on EDGAR.

What they were paid

NovoCure Director Compensation Table · the one fiscal year held
In US dollars, as NovoCure reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$0$0—$0$13,071,872

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: NovoCure Ltd DEF 14A filed April 20, 2026, accession 0001645113-26-000033, and prior-year filings. Open the filing on EDGAR.

The rest of the NovoCure board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Allyson OceanIndependent Director$437,044
David HungIndependent Director$438,044
Frank LeonardDirector$0
Jeryl HillemanIndependent Director$455,044
Kinyip Gabriel LeungIndependent Director$443,044
Kristin StaffordIndependent Director$440,044
Martin MaddenIndependent Director$455,047
Timothy ScannellIndependent Director$445,044
William DoyleChair of the Board$1,777,965
William VernonLead Independent Director$485,044

The full NovoCure compensation record

free company brief

This page is one director within NovoCure's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy